Examining how infants of depressed mothers respond to emotional faces
Official title: Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
Run by Binghamton University · NCT06835855 · Data updated 2026-11-12
This study looks at how babies of mothers with depression react to different facial expressions to see if they pay more attention to certain emotions compared to babies of mothers without depression.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Months and up |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | Binghamton University Academic / other |
| Locations | 1 site (Binghamton, New York) |
| Status | Recruiting |
| Started | November 14, 2024 |
| Main results expected | February 2029 |
| Study ends | July 2029 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06835855 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include infants of mothers who have experienced at least one episode of major depressive disorder since the birth of their child.
✕Probably not a fit
Patients who may not benefit include infants of mothers with no history of depressive disorders or those with significant health complications.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how infants of mothers with postpartum major depression exhibit attentional biases towards different emotional facial expressions. Infants will participate in a computer-based task while their gaze is tracked, and they will also engage in standardized interaction tasks with their mothers. The study aims to understand the role of infant arousal in developing these biases, comparing infants of depressed mothers to those of non-depressed mothers. The research will involve observing infant behavior in both free play and structured emotional contexts.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the developmental risks faced by infants of depressed mothers, potentially leading to early interventions.
How similar studies have gone: Other studies have explored similar themes regarding maternal depression and infant development, indicating a growing body of evidence in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The high-risk group (n = 150) will consist of women with at least one episode of MDD since their baby's birth. * To qualify for the low-risk group (n = 75), women cannot have a history of any depressive disorder or any current psychiatric diagnoses. * Infants will be required to be singleton children born full-term (\> 37 weeks) and normal weight (\> 2,500 grams) with no birth complications or health problems to avoid medical complications contributing to infants' attention, reactivity, and regulation measures. * The two groups will be matched on demographic factors (e.g., age, race/ethnicity, income). Exclusion Criteria: * Additional exclusion criteria are diagnoses of alcohol or substance use disorders currently or at any point during pregnancy, or lifetime history of bipolar or psychotic disorders.
Where it's running
-
Binghamton University
Binghamton, New York, United States Recruiting
Study contacts
- Study coordinator: Brandon E Gibb, Ph.D.
- Email: bgibb@binghamton.edu
- Phone: 607-777-2511
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Medically tailored groceries to help depression in people with food insecurity
This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.
-
Health and Work Ability After Inpatient Treatment for Stress-Related Disorders: Follow-Up of the HARMODI Cohort
This study follows people who had inpatient treatment for stress-related disorders to see how their health and ability to work change over the next three years and what factors help them return to work.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.